Indeed, patient-derived AML cells engraftment enabled the identification of leukemia-initiating cells (LIC), expressing CD34+ CD38− surface markers, recapitulating the human HSCs signature [202]. The gene discussed is CD34; the disease is acute myeloid leukemia.